| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.037 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |